Welcome to CDC Stacks | Cause-specific mortality among HIV-infected individuals, by CD4+ cell count at HAART initiation, compared with HIV-uninfected individuals - 30119 | CDC Public Access
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Cause-specific mortality among HIV-infected individuals, by CD4+ cell count at HAART initiation, compared with HIV-uninfected individuals
Filetype[PDF - 380.43 KB]


Details:
  • Pubmed ID:
    24105030
  • Pubmed Central ID:
    PMC4164055
  • Description:
    Objectives

    To compare the proportion, timing and hazards of non-AIDS death and AIDS death among men and women who initiated HAART at different CD4+ cell counts to mortality risks of HIV-uninfected persons with similar risk factors.

    Design

    Prospective cohort studies.

    Methods

    We used parametric mixture models to compare proportions of AIDS and non-AIDS mortality and ages at death, and multivariable Cox models to compare cause-specific hazards of mortality, across levels of CD4+ cell count at HAART initiation (≤200 cells/μl: ‘late’, 201–350 cells/μl: ‘intermediate’, >350 cells/μl: ‘early’) and with HIV-uninfected individuals from the Multicenter AIDS Cohort Study and the Women’s Interagency HIV Study. We used multiple imputation methods to address lead-time bias in sensitivity analysis.

    Results

    Earlier initiators were more likely to die of non-AIDS causes (early: 78%, intermediate: 74%, late: 49%), and at older ages (median years 72, 69, 66), relative to later initiators. Estimated median ages at non-AIDS death for each CD4+ cell count category were lower than that estimated for the HIV-uninfected group (75 years). In multivariable analysis, non-AIDS death hazard ratios relative to early initiators were 2.15 for late initiators (P < 0.01) and 1.66 for intermediate initiators (P = 0.01); AIDS death hazard ratios were 3.26 for late initiators (P <0.01) and 1.20 for intermediate initiators (P = 0.28). Strikingly, the adjusted hazards for non-AIDS death among HIV-uninfected individuals and early initiators were nearly identical (hazard ratio 1.01). Inferences were unchanged after adjustment for lead-time bias.

    Conclusion

    Results suggest the possibility of reducing the risk of non-AIDS mortality among HIV-infected individuals to approximate that faced by comparable HIV-uninfected individuals.

  • Document Type:
  • Collection(s):
  • Funding:
    MO1-RR-00071/RR/NCRR NIH HHS/United States
    MO1-RR-00079/RR/NCRR NIH HHS/United States
    MO1-RR-00083/RR/NCRR NIH HHS/United States
    U01 AI031834/AI/NIAID NIH HHS/United States
    U01 AI034989/AI/NIAID NIH HHS/United States
    U01 AI034993/AI/NIAID NIH HHS/United States
    U01 AI034994/AI/NIAID NIH HHS/United States
    U01 AI035004/AI/NIAID NIH HHS/United States
    U01 AI035039/AI/NIAID NIH HHS/United States
    U01 AI035040/AI/NIAID NIH HHS/United States
    U01 AI035041/AI/NIAID NIH HHS/United States
    U01 AI035042/AI/NIAID NIH HHS/United States
    U01 AI042590/AI/NIAID NIH HHS/United States
    U01 HD032632/HD/NICHD NIH HHS/United States
    UL1 RR025005/RR/NCRR NIH HHS/United States
    UL1-RR025005/RR/NCRR NIH HHS/United States
    UM1 AI035043/AI/NIAID NIH HHS/United States
    UM1-AI-35043/AI/NIAID NIH HHS/United States
    UO1-AI-31834/AI/NIAID NIH HHS/United States
    UO1-AI-34989/AI/NIAID NIH HHS/United States
    UO1-AI-34993/AI/NIAID NIH HHS/United States
    UO1-AI-34994/AI/NIAID NIH HHS/United States
    UO1-AI-35004/AI/NIAID NIH HHS/United States
    UO1-AI-35039/AI/NIAID NIH HHS/United States
    UO1-AI-35040/AI/NIAID NIH HHS/United States
    UO1-AI-35041/AI/NIAID NIH HHS/United States
    UO1-AI-35042/AI/NIAID NIH HHS/United States
    UO1-AI-42590/AI/NIAID NIH HHS/United States
    UO1-CH-32632/CH/OID CDC HHS/United States
No Related Documents.
You May Also Like: